Current and historical daily PE Ratio for Cytogen Inc (
) from 2018 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cytogen stock (XKRX:217330) PE ratio as of Sep 21 2024 is 0.
More Details
Cytogen Inc (XKRX:217330) PE Ratio (TTM) Chart
Cytogen Inc (XKRX:217330) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1284
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Cytogen PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-09-21 | At Loss | 2024-07-16 | At Loss |
| 2024-09-20 | At Loss | 2024-07-15 | At Loss |
| 2024-09-19 | At Loss | 2024-07-12 | At Loss |
| 2024-09-13 | At Loss | 2024-07-11 | At Loss |
| 2024-09-12 | At Loss | 2024-07-10 | At Loss |
| 2024-09-11 | At Loss | 2024-07-09 | At Loss |
| 2024-09-10 | At Loss | 2024-07-08 | At Loss |
| 2024-09-09 | At Loss | 2024-07-05 | At Loss |
| 2024-09-06 | At Loss | 2024-07-04 | At Loss |
| 2024-09-05 | At Loss | 2024-07-03 | At Loss |
| 2024-09-04 | At Loss | 2024-07-02 | At Loss |
| 2024-09-03 | At Loss | 2024-07-01 | At Loss |
| 2024-09-02 | At Loss | 2024-06-28 | At Loss |
| 2024-08-30 | At Loss | 2024-06-27 | At Loss |
| 2024-08-29 | At Loss | 2024-06-26 | At Loss |
| 2024-08-28 | At Loss | 2024-06-25 | At Loss |
| 2024-08-27 | At Loss | 2024-06-24 | At Loss |
| 2024-08-26 | At Loss | 2024-06-21 | At Loss |
| 2024-08-23 | At Loss | 2024-06-20 | At Loss |
| 2024-08-22 | At Loss | 2024-06-19 | At Loss |
| 2024-08-21 | At Loss | 2024-06-18 | At Loss |
| 2024-08-20 | At Loss | 2024-06-17 | At Loss |
| 2024-08-19 | At Loss | 2024-06-14 | At Loss |
| 2024-08-16 | At Loss | 2024-06-13 | At Loss |
| 2024-08-14 | At Loss | 2024-06-12 | At Loss |
| 2024-08-13 | At Loss | 2024-06-11 | At Loss |
| 2024-08-12 | At Loss | 2024-06-10 | At Loss |
| 2024-08-09 | At Loss | 2024-06-07 | At Loss |
| 2024-08-08 | At Loss | 2024-06-05 | At Loss |
| 2024-08-07 | At Loss | 2024-06-04 | At Loss |
| 2024-08-06 | At Loss | 2024-06-03 | At Loss |
| 2024-08-05 | At Loss | 2024-05-31 | At Loss |
| 2024-08-02 | At Loss | 2024-05-30 | At Loss |
| 2024-08-01 | At Loss | 2024-05-29 | At Loss |
| 2024-07-31 | At Loss | 2024-05-28 | At Loss |
| 2024-07-30 | At Loss | 2024-05-27 | At Loss |
| 2024-07-29 | At Loss | 2024-05-24 | At Loss |
| 2024-07-26 | At Loss | 2024-05-23 | At Loss |
| 2024-07-25 | At Loss | 2024-05-22 | At Loss |
| 2024-07-24 | At Loss | 2024-05-21 | At Loss |
| 2024-07-23 | At Loss | 2024-05-20 | At Loss |
| 2024-07-22 | At Loss | 2024-05-17 | At Loss |
| 2024-07-19 | At Loss | 2024-05-16 | At Loss |
| 2024-07-18 | At Loss | 2024-05-14 | At Loss |
| 2024-07-17 | At Loss | 2024-05-13 | At Loss |
Cytogen Inc (XKRX:217330) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Cytogen Inc
ISIN : KR7217330000
Share Class Description:
XKRX:217330: Ordinary SharesCompare
Compare
Traded in other countries / regions
217330.Korea IPO Date
2018-11-22Description
Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers